Director/PDMR Shareholding

RNS Number : 2465Q

Port Erin Biopharma Investments Ltd

14 October 2011

 



14 October 2011

Port Erin Biopharma Investments Limited

("Port Erin" or the "Company")

Director's Dealing

Port Erin, the newly formed AIM listed company focused on investing in the biotechnology and biopharmaceutical sectors, announces that the Company was today notified that Mr Jim Mellon, the Non-executive Chairman of Port Erin, today acquired 240,000 ordinary shares of 0.0001 pence each ("Ordinary Shares") at a price of 8.25 pence per Ordinary Share. Accordingly, Mr Mellon is now interested, in aggregate, in 3,340,000 Ordinary Shares representing approximately 10.12 per cent. of the Company's issued share capital.

Enquiries:

Libertas Capital Corporate Finance Limited

Sandy Jamieson                                                                                    0207 569 9650

Rivington Street Corporate Finance Limited

Dru Edmonstone/ Jon Levinson                                                               0207 562 3389

 

END

 

 

RDSEZLFFFBFZFBL